Breaking News, Collaborations & Alliances

Pii to Manufacture FDA Approved Injection Drug Product

Academic Pharmaceuticals received FDA approval of Bretylium Tosylate Injection USP, 500 mg/10 mL (50 mg/mL) Single-Dose Vials on December 21, 2018

Pharmaceutics International, Inc. (Pii) has announced its partner, Academic Pharmaceuticals, Inc., received FDA approval of Bretylium Tosylate Injection USP, 500 mg/10 mL (50 mg/mL) Single-Dose Vials on December 21, 2018.     Bretylium Tosylate Injection is indicated for the prophylaxis and therapy of ventricular fibrillation; treatment of life-threatening ventricular arrhythmia that has failed to respond to first-line antiarrhythmic agents.  Pii is the exclusive manufacturer of Bretyliu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters